Free Trial

ABVC BioPharma (ABVC) SEC Filings & 10K Form

ABVC BioPharma logo
$1.15 -0.06 (-4.96%)
Closing price 04:00 PM Eastern
Extended Trading
$1.14 0.00 (-0.43%)
As of 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ABVC BioPharma SEC Filings

DateFilerForm TypeView
05/20/2025
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
05/20/2025
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
05/14/2025
7:30 AM
ABVC BioPharma (Filer)
Form 8-K/A
05/06/2025
3:30 PM
ABVC BioPharma (Filer)
Form 8-K/A
05/02/2025
3:30 PM
ABVC BioPharma (Filer)
Form 8-K/A
05/01/2025
7:00 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
3:41 PM
ABVC BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/16/2025
12:42 PM
ABVC BioPharma (Filer)
Form 8-K/A
04/15/2025
3:30 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:13 PM
ABVC BioPharma (Subject)
Lind Global Fund II LP (Filed by)
Form SCHEDULE 13G/A
11/15/2024
2:26 PM
ABVC BioPharma (Filer)
Form 424B4
11/15/2024
2:28 PM
ABVC BioPharma (Filer)
Form 424B4
11/15/2024
2:30 PM
ABVC BioPharma (Filer)
Form 424B4
11/15/2024
2:31 PM
ABVC BioPharma (Filer)
Form 424B4
11/14/2024
6:33 PM
ABVC BioPharma (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G/A
11/14/2024
8:25 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:30 AM
ABVC BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
4:00 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
11:21 AM
ABVC BioPharma (Filer)
Form 424B4
10/18/2024
4:23 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:01 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:30 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:30 PM
ABVC BioPharma (Filer)
Form 424B4
08/16/2024
3:30 PM
ABVC BioPharma (Filer)
Form 424B4
08/16/2024
3:31 PM
ABVC BioPharma (Filer)
Form 424B4
08/15/2024
6:00 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
2:18 PM
ABVC BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
4:15 PM
ABVC BioPharma (Filer)
Form 424B5
08/01/2024
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
07/26/2024
3:30 PM
ABVC BioPharma (Filer)
Form POS AM
07/23/2024
4:00 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
06/25/2024
4:15 PM
ABVC BioPharma (Filer)
Form 8-K/A
06/24/2024
4:15 PM
ABVC BioPharma (Filer)
Form 8-K/A
06/21/2024
4:02 PM
ABVC BioPharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/24/2024
7:00 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
4:00 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ABVC) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners